학술논문
A Randomized Phase I Study of the Anti-Interleukin-33 Antibody Tozorakimab in Healthy Adults and Patients With Chronic Obstructive Pulmonary Disease
Document Type
Article
Author
Source
In: Clinical Pharmacology and Therapeutics . (Clinical Pharmacology and Therapeutics, March 2024, 115(3):565-575)
Subject
Language
English
ISSN
15326535
00099236
00099236